Literature DB >> 9558342

Role of base G-2 of pre-tRNAfMet in cleavage site selection by Escherichia coli RNase P in vitro.

M Lazard1, T Meinnel.   

Abstract

In this study, a protocol for the purification of fully active Escherichia coli RNase P holoenzyme from a strain overproducing both the C5 protein and the M1 RNA components is described. A total of 0. 8 mg of homogeneous enzyme, with a 1:1 protein/RNA subunit stoichiometry, was recovered from a 1 L bacterial culture. In addition, a convenient and reliable method based on capillary gel electrophoresis was developed to measure initial rates of pre-tRNA maturation by RNase P. Using these tools, the kinetic parameters of cleavage by RNase P of various mutants of pre-tRNAfMet showing maturation defects in vivo [Meinnel and Blanquet (1995) J. Biol. Chem. 270, 15906-15914] were investigated in vitro and the locations of cleavage sites were determined from the length of the various products of the reaction. The nucleotide at position -2 of pre-tRNAfMet is shown to be important only in the selection of the cleavage site, whereas it has no role in the efficiency of the reaction. It is concluded that base G-2 acts as an antideterminant by preventing an alternative cleavage by RNase P. In addition, the presence of G-2 alone is enough to fully compensate for the lack of a G at position +1 of pre-tRNAfMet.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558342     DOI: 10.1021/bi972771u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  In vivo display of a multisubunit enzyme complex on biogenic magnetic nanoparticles.

Authors:  Shoji Ohuchi; Dirk Schüler
Journal:  Appl Environ Microbiol       Date:  2009-10-16       Impact factor: 4.792

2.  Binding of C5 protein to P RNA enhances the rate constant for catalysis for P RNA processing of pre-tRNAs lacking a consensus (+ 1)/C(+ 72) pair.

Authors:  Lei Sun; Frank E Campbell; Lindsay E Yandek; Michael E Harris
Journal:  J Mol Biol       Date:  2009-11-13       Impact factor: 5.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.